HMGCR and cardiovascular disorder: Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (12, 13), have lipid-lowering activity and are commonly used clinically to treat cardiovascular diseases (14, 15).